drugset / Trial / NCT05445440
A Study to Assess the Effects of BMS-986371 on the Drug Levels of Methotrexate in the Presence and Absence of Sulfasalazine
Non-randomizedSequentialOpen-labelTreatment
Summary
The purpose of this study is to evaluate the effects of BMS-986371 on the drug levels of methotrexate, sulfasalazine and their main metabolites in healthy male adult participants.
Timeline
- Start
- 2022-09-06
- Primary completion
- 2022-11-17
- Completion
- 2022-11-23
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | GAMCEMETINIB | Small molecule | — | — |
| Subject | Methotrexate | Small molecule | — | — |
| Subject | Sulfasalazine | Small molecule | — | — |
| Background | Leucovorin | Small molecule | — | — |
Indications
No indication recorded.